RPG Life Sciences (RPGLIFE) Share Price rises 5.29% as stock trades at Rs 3,108.95

RPG Life Sciences Share Price is in focus today after the stock rose 5.29% to Rs 3,108.95, taking market capitalisation to Rs 5,021.41 crore. The move places RPGLIFE among the notable gainers in today’s market, even as no company-specific catalyst is established. Univest figures confirm the price action, but they do not point to a specific company trigger. For readers tracking RPG Life Sciences Share Price Today, the immediate takeaway is simple: the share price rise is visible in the latest price action, while the broader valuation picture remains important for context. Univest data also shows that the company trades in the Healthcare sector and the Pharmaceuticals & Drugs industry, where fundamentals and peer benchmarks help explain why RPG Life Sciences Stock News is drawing attention.

RPG Life Sciences Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 3,108.95
Previous Close	Rs 2,952.8
Today's Move	Rs 156.15 (+5.29%)
Open	Rs 2,987.95
High	Rs 3,117.85
Low	Rs 2,929.6
Market Capitalisation	Rs 5,021.41 crore
Market Cap Category	Mid Cap

RPG Life Sciences Ltd. (RPGLIFE) rose to Rs 3,108.95 from the previous close of Rs 2,952.8, a move of Rs 156.15 or 5.29%. The stock opened at Rs 2,987.95, reached a high of Rs 3,117.85, recorded a low of Rs 2,929.6.

RPG Life Sciences Share Price today reflects a clear intraday price rise, with the stock last traded at Rs 3,108.95 after opening at Rs 2,987.95. The share price move took the stock above the previous close of Rs 2,952.8 by Rs 156.15, while the day’s range stretched from Rs 2,929.6 to Rs 3,117.85. That range shows the stock trading close to its intraday high at the time of this update.

For traders following RPG Life Sciences Share Price Live, the sequence matters: the stock moved up from the open, traded above the prior close and stayed within a range that kept it firmly in the day’s action. This is the core of today’s RPG Life Sciences Share Price update, and it explains why the name is appearing in Stocks in News and Top Gainers Today discussions. The price action itself does not establish why the move occurred, so the next step is to read the fundamentals alongside the valuation profile.

RPG Life Sciences Ltd. (RPGLIFE) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 5,021.41 crore
P/E Ratio	42.4x
P/B Ratio	7.68x
ROE	20.28%
ROCE	26.99%
EPS	Rs 69.64
Book Value Per Share	Rs 384.61
Dividend Yield	0.81%

RPG Life Sciences Ltd. (RPGLIFE) fundamental metrics show P/E 42.4x, P/B 7.68x, ROE 20.28%, ROCE 26.99%. Taken on their own, these numbers offer context rather than a trading signal.

RPG Life Sciences Ltd. has a market capitalisation of Rs 5,021.41 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 42.4x, P/B at 7.68x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.28% and ROCE of 26.99%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 69.64, book value per share of Rs 384.61, dividend yield of 0.81%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.59x, median ROE of 11.7%, median ROCE of 13.61%. They set out the fundamental picture and are not a rating on the stock.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	42.4x
Benchmark Median P/E	32.59x
Benchmark Average P/E	49x
Benchmark P/E Range	3.46x to 707.31x
Company P/B Ratio	7.68x
Benchmark Median P/B	2.88x
Company ROE	20.28%
Benchmark Median ROE	11.7%
Company ROCE	26.99%
Benchmark Median ROCE	13.61%
Company Market Capitalisation	Rs 5,021.41 crore
Benchmark Median Market Cap	Rs 783.26 crore

RPG Life Sciences Ltd. (RPGLIFE) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

RPG Life Sciences Ltd. (RPGLIFE) has a P/E ratio of 42.4x, which is above the benchmark median of 32.59x, a difference of +30.1%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

RPG Life Sciences Ltd. (RPGLIFE) has a ROE of 20.28%, which is above the benchmark median of 11.7%, a difference of +73.33%. RPG Life Sciences Ltd. (RPGLIFE) has a ROCE of 26.99%, which is above the benchmark median of 13.61%, a difference of +98.31%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,44,716.74	36.5	5.1	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,55,115.31	86.51	14.33	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,89,613.38	84.92	20.64	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,19,899.96	26.79	4.48	19.69	21.39
Cipla Ltd.	CIPLA	1,12,875.68	33.29	3.19	11.83	16

RPG Life Sciences Ltd. (RPGLIFE) has a P/E ratio of 42.4x compared with the displayed peer median of 36.5x. The comparison is relative and should not be read as a recommendation. Its ROE of 20.28% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 26.99% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. RPG Life Sciences Ltd. (RPGLIFE) has a market capitalisation of Rs 5,021.41 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching RPG Life Sciences

• RPG Life Sciences Share Price rose 5.29% and is trading near the upper end of the day’s range.
• The stock’s P/E of 42.4 and P/B of 7.68 keep valuation central to RPG Life Sciences Stock News.
• ROE of 20.28% and ROCE of 26.99% give useful context for RPG Life Sciences Fundamental Analysis.
• Market capitalisation of Rs 5,021.41 crore places RPG Life Sciences Share Price in a clearly established listed healthcare profile.
• The company stands above industry median return ratios, which is relevant for RPG Life Sciences Stock Performance tracking.

About RPG Life Sciences

RPG Life Sciences Ltd. operates in Healthcare and the Pharmaceuticals & Drugs industry. RPG Life Sciences Share Price is tied to a business that belongs to the broader pharmaceutical value chain, where product quality, regulatory execution and portfolio mix matter to investors. The available company context places the stock within a sector that is often compared on profitability, capital efficiency and valuation rather than on short-term market chatter alone.

From a company overview perspective, RPG Life Sciences Share Price reflects a listed pharmaceutical business with a market capitalisation above the industry median and a return profile that screens stronger than the broader industry middle. For readers following RPG Life Sciences Company News, the most relevant framing is not a hype cycle but a steady read of company financials, sector benchmark context and valuation. Univest tracks this kind of profile because it helps separate a day’s price rise from the underlying business lens that investors typically use for stock analysis and fundamental analysis.

Frequently Asked Questions

Why is RPG Life Sciences Share Price rising today?

Ans. RPG Life Sciences Share Price is rising today because the stock is up 5.29% and trading at Rs 3,108.95. Univest figures confirm the price action, but they do not point to a specific company trigger.

What is RPG Life Sciences Share Price today?

Ans. RPG Life Sciences Share Price today is Rs 3,108.95. The stock is up Rs 156.15 from the previous close of Rs 2,952.8, keeping RPG Life Sciences Share Price in today’s market focus.

What is the market capitalisation of RPG Life Sciences?

Ans. RPG Life Sciences has a market capitalisation of Rs 5,021.41 crore. That size helps frame RPG Life Sciences Share Price against its healthcare peers and provides useful context for RPG Life Sciences Stock Analysis.

Is RPG Life Sciences Share Price expensive on valuation?

Ans. RPG Life Sciences Share Price trades at a P/E of 42.4 and a P/B of 7.68. Those numbers sit above the industry median, so the valuation looks richer than the broader benchmark.

How do ROE and ROCE look for RPG Life Sciences?

Ans. RPG Life Sciences reports ROE of 20.28% and ROCE of 26.99%. Both are above the industry median and average, which supports the fundamental context behind RPG Life Sciences Share Price today.

What do EPS and book value show for RPG Life Sciences?

Ans. RPG Life Sciences has EPS of 69.64 and book value of Rs 384.61. EPS shows earnings per share, while book value shows accounting net worth behind each share in RPG Life Sciences Share Price.

How does RPG Life Sciences compare with peers?

Ans. RPG Life Sciences Share Price is backed by a smaller market capitalisation than major peers like Sun Pharmaceutical Industries Ltd. and Divi’s Laboratories Ltd., but its return ratios compare well with several listed names.

What should investors watch next in RPG Life Sciences Share Price?

Ans. Investors should watch whether RPG Life Sciences Share Price holds near today’s range, how valuation compares with peers, and whether sector context continues to support the current premium versus the industry median.

Track RPG Life Sciences Share Price on Univest

Use RPG Life Sciences Ltd. (RPGLIFE) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Readers can track RPG Life Sciences Share Price on Univest for live price movement, market capitalisation, P/E ratio, P/B ratio, ROE, ROCE, EPS, book value and dividend yield. The same page also helps users follow RPG Life Sciences Share Price Today alongside 52-week levels and company context. Univest keeps the focus on verified price action, stock analysis and fundamental analysis so that RPG Life Sciences Share Price can be reviewed in one place with broader healthcare sector context.